{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T22:41:56Z","timestamp":1772664116760,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"please see title page"},{"DOI":"10.13039\/501100018934","name":"Universit\u00e4t Greifswald","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018934","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Health Econ"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>When choosing between different treatment options, implants often appear too costly. However, this perspective does not take future costs into account. This article evaluates lifetime costs for different surgical interventions to treat hearing loss.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The analysis focused on three groups from the perspective of health insurers. Group 1 comprises patients who have only been implanted with a middle ear implant. Patients in Group 2 had already undergone middle ear surgery to improve hearing prior to the implantation of a middle ear implant. Group 3 consists of patients who were treated exclusively with hearing-improvement surgeries (no implant). The lifetime costs were calculated using the Monte Carlo simulation. The inputs were based on medical data from a maximum-care hospital and data from the German healthcare system.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Based on an average observation period of 26.73\u00a0years, the lifetime costs amounted to 28,325\u20ac for group 1, 32,187\u20ac for group 2 and 28,381\u20ac for group 3. While the mean values between groups 1 and 3 appear comparable, group 1 has a significantly lower standard deviation (G1 vs. G3: 6120\u20ac vs. 10,327\u20ac).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion\/conclusion<\/jats:title>\n            <jats:p>Choosing a treatment option can be a complex medical decision and impose a substantial economic burden for the statutory health insurance. Hence, treatment decisions should be patient-centred at first but also including a shared-decision making on economic feasibility, whether proposed treatment alternatives are likely to be successful and economically reasonable.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s10198-024-01743-6","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T02:31:22Z","timestamp":1733452282000},"page":"797-816","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Expensive today but cheaper tomorrow: lifetime costs of an active middle ear implant compared to alternative treatment options"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9354-1150","authenticated-orcid":false,"given":"Markus","family":"Krohn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaas","family":"Kiesewetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Buchholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Schlick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Busch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Lenarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke","family":"Lesinski-Schiedat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannes","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia","family":"Batsoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Urban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Flessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"key":"1743_CR1","unstructured":"RI Innovation GmbH: DRG D30B. https:\/\/app.reimbursement.info\/drgs\/D06B?s=D06B (2023)"},{"key":"1743_CR2","unstructured":"Charit\u00e9: Entgelttarif f\u00fcr Krankenh\u00e4user im Anwendungsbereich des Krankenhausentgeltgesetzes (KHEntgG) und der Bundespflegesatzverordnung (BPflV) sowie Unterrichtung der Patientinnen und Patienten gem\u00e4\u00df \u00a7 8 KHEntgG \/ \u00a7 8 BPflV. https:\/\/www.charite.de\/fileadmin\/user_upload\/portal\/klinikum\/behandlung_stationaer\/Entgelttarif.pdf (2023)"},{"key":"1743_CR3","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.21.285643","author":"S Chadha","year":"2021","unstructured":"Chadha, S., Kamenov, K., Cieza, A.: The world report on hearing, 2021. Bull World Health Organ (2021). https:\/\/doi.org\/10.2471\/BLT.21.285643","journal-title":"Bull World Health Organ"},{"key":"1743_CR4","unstructured":"Neubauer, G., Gmeiner, A.: Volkswirtschaftliche Bedeutung von H\u00f6rsch\u00e4den und M\u00f6glichkeiten zur Reduktion deren Folgekosten. https:\/\/www.kbv.de\/media\/sp\/120811_studie_ifg_abschlussbericht.pdf (2011)"},{"key":"1743_CR5","unstructured":"Schield, B.: Hearing Loss \u2013 Numbers and Costs. EVALUATION OF THE SOCIAL AND ECONOMIC COSTS OF HEARING IMPAIRMENT A report for Hear-It AISBL. https:\/\/www.ehima.com\/wp-content\/uploads\/2021\/01\/Hear-it-Report-Hearing-Loss-Numbers-and-Costs-2019.pdf (2019)"},{"key":"1743_CR6","unstructured":"Institute for Health Metrics and Evaluation (IHME): GBD Compare. http:\/\/vizhub.healthdata.org\/gbd-compare (2015). Accessed 15 Jun 2024"},{"key":"1743_CR7","first-page":"945","volume":"276","author":"J L\u00f6hler","year":"2019","unstructured":"L\u00f6hler, J., Walther, L.E., Hansen, F., Kapp, P.C., Meerpohl, J.J., Wollenberg, B., Sch\u00f6nweiler, R., Schmucker, C.: The prevalence of hearing loss and use of hearing aids among adults in Germany. A systematic review. Eur Arch Otorhinolaryngol Head Neck 276, 945\u2013956 (2019)","journal-title":"Eur Arch Otorhinolaryngol Head Neck"},{"key":"1743_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-019-7602-7","volume-title":"Prevalence of hearing loss and use of hearing aids among children and adolescents in Germany: a systematic review","author":"C Schmucker","year":"2019","unstructured":"Schmucker, C., Kapp, P.C., Motschall, E., L\u00f6hler, J., Meerpohl, J.J.: Prevalence of hearing loss and use of hearing aids among children and adolescents in Germany: a systematic review. Universit\u00e4t, Freiburg (2019)"},{"key":"1743_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00106-014-2949-7","author":"P von Gablenz","year":"2015","unstructured":"von Gablenz, P., Holube, I.: Pr\u00e4valenz von Schwerh\u00f6rigkeit im Nordwesten Deutschlands: Ergebnisse einer epidemiologischen Untersuchung zum H\u00f6rstatus (H\u00d6RSTAT). HNO (2015). https:\/\/doi.org\/10.1007\/s00106-014-2949-7","journal-title":"HNO"},{"key":"1743_CR10","first-page":"341","volume":"30","author":"F Dispenza","year":"2018","unstructured":"Dispenza, F., Battaglia, A.-M., Salvago, P., Martines, F.: Determinants of failure in the reconstruction of the tympanic membrane: a case-control study. Iran J Otorhinolaryngol 30, 341\u2013346 (2018)","journal-title":"Iran J Otorhinolaryngol"},{"key":"1743_CR11","unstructured":"InEK: Institut f\u00fcr das Entgeltsystem im Krankenhaus - Fallpauschalen-Katalog 2023. https:\/\/www.g-drg.de\/ag-drg-system-2023\/fallpauschalen-katalog\/fallpauschalen-katalog-20232 (2022)"},{"key":"1743_CR12","unstructured":"Universit\u00e4tsklinikum Erlangen: Fd-91\u201301 DRG-Entgelttarif und Pflegekostentarif 2023. erlangen.de\/fileadmin\/dateien\/patienten\/patienten_a-z\/Pflegekostentarif_DRG.pdf (2022)"},{"key":"1743_CR13","unstructured":"Katholisches Klinikum Bochum: DRG-Entgelttarif im Anwendungsbereich des KHEntgG Unterrichtung des Pateinten gem\u00e4\u00df \u00a78 KHEntgG. https:\/\/www.klinikum-bochum.de\/avb.html?file=files\/klinikum-bochum\/dokumente\/AVB\/2023-09%20DRG-Entgelttarif%20inkl.MLK.pdf (2023)"},{"key":"1743_CR14","unstructured":"Klinikum N\u00fcrnberg: Entgelttarif des Klinikum N\u00fcrnberg und Unterrichtung der Patienten gem\u00e4\u00df \u00a7 8 Abs. 9 KHEntgG bzw. \u00a7 8 Abs. 5 BPflV. https:\/\/www.klinikum-nuernberg.de\/fileadmin\/user_upload\/Flyer_Dokumente_Verwaltung\/Patientenaufnahme_und_Leistungsabrechnung\/Entgelttarif_01.11.2023_Version_1.0_feu_25102023.pdf (2023)"},{"key":"1743_CR15","unstructured":"Klinikum Stuttgart: DRG-Entgelttarif (gem\u00e4\u00df Krankenhausentgeltgesetz (KHEntgG)) und PEPP-Entgelttarif (gem\u00e4\u00df Bundespflegesatzverordnung (BPflV)). https:\/\/www.klinikum-stuttgart.de\/fileadmin\/mediapool\/downloads\/230220_EntgeltTarif_KlinikumStuttgart_m_Anlagen.pdf (2023)"},{"key":"1743_CR16","unstructured":"Medizinische Hochschule Hannover: DRG und PEPP Entgelt- und Behandlungskostentarif Unterrichtung des Patienten gem\u00e4\u00df \u00a7 8 Abs. 8 KHEntgG und \u00a7 8 Abs. 5 BPflV. https:\/\/www.mhh.de\/fileadmin\/mhh\/gb-klinikmanagement\/downloads\/210105_DRG-Entgelt-_und_Behandlungskostentarif_ohne_Fusszeile.pdf (2021)"},{"key":"1743_CR17","unstructured":"Universit\u00e4tsklinikum Bonn: Entgelttarif 2021 Unterrichtung des Patienten gem\u00e4\u00df \u00a7 8 KHEntgG. https:\/\/www.ukbonn.de\/site\/assets\/files\/18552\/drg_entgelttarif_01072021.pdf (2021)"},{"key":"1743_CR18","unstructured":"Universit\u00e4tsklinikum Ulm: aDRG Entgelttarif f\u00fcr das Universit\u00e4tsklinikum Ulm Unterrichtung des Patienten gem\u00e4\u00df \u00a7 8 KHEntgG Abs.8 (Krankenhausentgeltgesetz). http:\/\/www.universitaetsklinik-ulm.de\/fileadmin\/default\/05_Uber-uns\/DRG_Entgelttarif_fuer_das_Universitaetsklinikum_01_2020_Version_2.pdf (2020)"},{"key":"1743_CR19","unstructured":"Universit\u00e4tsmedizin G\u00f6ttingen: Krankenhausentgelttarif g\u00fcltig ab 01.01.2022 f\u00fcr station\u00e4re und teilstation\u00e4re Behandlung in der Universit\u00e4tsmedizin G\u00f6ttingen (2022)"},{"key":"1743_CR20","unstructured":"Harrell, C., Ghosh, B.K., Bowden, R.: Simulation using ProModel. McGraw-Hill series in industrial engineering and management science. McGraw-Hill, Boston, Mass. (2000)"},{"key":"1743_CR21","doi-asserted-by":"publisher","DOI":"10.1515\/9783110753103","volume-title":"Systemisches Krankenhausmanagement","author":"S Fle\u00dfa","year":"2022","unstructured":"Fle\u00dfa, S.: Systemisches Krankenhausmanagement, 2nd edn. De Gruyter Studium, Berlin (2022)","edition":"2"},{"key":"1743_CR22","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-963505","author":"SJM von der Graf","year":"2007","unstructured":"von der Graf, S.J.M., Greiner, W., Jost, F., Klusen, N., Kubin, M., Leidl, R., Mittendorf, T., Rebscher, H., Sch\u00f6ffski, O., Vauth, C., Volmer, T., Wahler, S., Wasem, J., Weber, C.: Deutsche Empfehlungen zur gesundheits\u00f6konomischen Evaluation - dritte und aktualisierte Fassung des Hannoveraner Konsens. Gesundheits\u00f6konomie Qualit\u00e4tsmanagement (2007). https:\/\/doi.org\/10.1055\/s-2007-963505","journal-title":"Gesundheits\u00f6konomie Qualit\u00e4tsmanagement"},{"key":"1743_CR23","unstructured":"GKV-Spitzenverband: Apparative Versorgung bei Schwerh\u00f6rigkeit. Begutachtungsanleitung (2020)"},{"key":"1743_CR24","unstructured":"Statistisches Bundesamt: Sterbef\u00e4lle und Lebenserwartung. https:\/\/www.destatis.de\/DE\/Themen\/Gesellschaft-Umwelt\/Bevoelkerung\/Sterbefaelle-Lebenserwartung\/_inhalt.html (2023)"},{"key":"1743_CR25","unstructured":"MED-EL Medical Electronics: VIBRANT SOUNDBRIDGE Middle Ear Implant. https:\/\/www.medel.com\/hearing-solutions\/vibrant-soundbridge (2023)"},{"key":"1743_CR26","unstructured":"Donau Vienna Insurance Group: Versicherung ausschlie\u00dflich f\u00fcr H\u00f6rsysteme der Firma MED-EL. https:\/\/www.vbk.co.at\/wp-content\/uploads\/2023\/04\/MED-EL-Antrag-04-2023.pdf (2022)"},{"key":"1743_CR27","doi-asserted-by":"publisher","DOI":"10.1159\/000502994","author":"N Wardenga","year":"2020","unstructured":"Wardenga, N., Diedrich, V., Waldmann, B., Lenarz, T., Maier, H.: Hearing aid treatment in patients with mixed hearing loss. Part I: expected benefit and limitations after stapes surgery. Audiol Neurotol (2020). https:\/\/doi.org\/10.1159\/000502994","journal-title":"Audiol Neurotol"},{"key":"1743_CR28","doi-asserted-by":"publisher","DOI":"10.1055\/a-1253-8325","author":"C Thum","year":"2021","unstructured":"Thum, C., Langenfeld, R., Flessa, S.: Lebenszeitkosten der H\u00f6rger\u00e4teversorgung in Deutschland (lifetime cost of hearing aids in Germany). Laryngorhinootologie (2021). https:\/\/doi.org\/10.1055\/a-1253-8325","journal-title":"Laryngorhinootologie"},{"key":"1743_CR29","doi-asserted-by":"publisher","DOI":"10.1159\/000504285","author":"N Wardenga","year":"2020","unstructured":"Wardenga, N., Snik, A.F.M., Kludt, E., Waldmann, B., Lenarz, T., Maier, H.: Hearing aid treatment for patients with mixed hearing loss. Part II: speech recognition in comparison to direct acoustic cochlear stimulation. Audiol Neurotol (2020). https:\/\/doi.org\/10.1159\/000504285","journal-title":"Audiol Neurotol"}],"container-title":["The European Journal of Health Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-024-01743-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10198-024-01743-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-024-01743-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T10:18:33Z","timestamp":1751019513000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10198-024-01743-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1743"],"URL":"https:\/\/doi.org\/10.1007\/s10198-024-01743-6","relation":{},"ISSN":["1618-7598","1618-7601"],"issn-type":[{"value":"1618-7598","type":"print"},{"value":"1618-7601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,6]]},"assertion":[{"value":"30 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was partly financed by MED-EL. The authors confirm that the results of this analysis were not influenced at all by this sponsorship.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}